A new therapeutic approach to diabetes that combines insulin and an inhibitor of the epidermal growth factor (EGF) betacellulin could limit the progression of diabetic macular edema (DME), researchers report.
..
.
Insulin plus growth factor inhibitor limits vision damage in diabetic mice
A new therapeutic approach to diabetes that combines insulin and an inhibitor of the epidermal growth factor (EGF) betacellulin could limit the progression of diabetic macular edema (DME), researchers report.
There are currently 1 users browsing this thread. (0 members and 1 guests)
Posting Permissions
Quote